Physician

Suresh Prasad, MD

According to 2025 Medicare claims, Suresh Prasad, MD (NPI: 1053419572) practices internal medicine in the Odessa, TX market, with the plurality of this provider's patient population coming from Ector, TX. This provider's primary affiliated billing organization is SURESH PRASAD MD PA (NPI: 1114012283; TIN: 510491501) and primary practice location at 79761-5423. Prasad is affiliated with the The Accountable Care Organization, Ltd. (ACO ID: A2098), participating under the MSSP model.

Prasad's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 463 traditional Medicare patients, billed 4,025 HCPCS/CPT codes, and received $202,648 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 4,620 prescription claims across 522 beneficiaries totaling $832,802 in drug costs, led by Ozempic (Semaglutide). DME data shows 1,872 claims. Open Payments data shows 2 records totaling $89. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $182,300 and ending at $202,648. Concurrently, Part D prescription costs have declined steadily, from $1,180,790 to $832,802. For DME billing, reported payments moved from a lower plateau to a higher plateau, from $48,540 to $116,470.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	563	4,298	$182,300
2016	624	5,479	$241,730
2017	580	5,003	$233,372
2018	577	4,840	$235,424
2019	513	3,732	$153,154
2020	503	3,645	$150,408
2021	494	3,852	$196,826
2022	485	3,377	$168,300
2023	491	4,547	$214,762
2024	463	4,025	$202,648

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	658	10,563	$1,180,790
2016	689	9,837	$1,067,080
2017	722	10,195	$1,201,622
2018	756	9,770	$1,134,939
2019	697	7,722	$982,259
2020	724	8,559	$1,109,494
2021	698	7,612	$968,510
2022	611	5,170	$763,129
2023	432	3,845	$682,643
2024	522	4,620	$832,802

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	467	1,142	$52,823
2016	659	1,527	$60,183
2017	761	1,676	$85,381
2018	895	2,077	$119,879
2019	759	1,975	$94,066
2020	864	2,105	$128,327
2021	834	2,149	$128,655
2022	832	1,793	$104,235
2023	781	1,804	$120,615
2024	791	1,872	$115,418

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	121	121	$124
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	243	601	$79
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	284	584	$57
G0444	Annual depression screening, 5 to 15 minutes	126	126	$18
96372	Injection of drug or substance under skin or into muscle	109	326	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	137	6,548	$205,633
Mounjaro	Tirzepatide	92	3,192	$118,735
Eliquis	Apixaban	50	2,860	$56,263
Tresiba Flextouch U-200	Insulin Degludec	64	3,366	$48,916
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	1,290	$27,630

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7031	Face mask interface, replacement for full face mask, each	N	76	149	$15,305
E0601	Continuous positive airway pressure (cpap) device	Y	62	401	$14,203
A7030	Full face mask used with positive airway pressure device, each	N	75	140	$13,302
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	29	$10,347
A4238	Supply allowance for adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	24	$10,262

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$89	Astellas Pharma US Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Suresh Prasad, MD?

Tedicare shows public-source Medicare data for Suresh Prasad, MD (NPI 1053419572), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Suresh Prasad, MD have ACO affiliation data?

Suresh Prasad, MD is shown with ACO affiliation data for The Accountable Care Organization, Ltd. (MSSP, ACO ID A2098).

What billing organization is linked to Suresh Prasad, MD?

Suresh Prasad, MD is linked to SURESH PRASAD MD PA (billing NPI 1114012283) in the available physician profile data.

Does Suresh Prasad, MD have Open Payments data?

Suresh Prasad, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.